Types of Startup Funding: What Each One Actually Costs You

Fewer than 0.05% of US startups ever raise a venture round.

Hold that number against how much of the internet’s startup advice assumes you will. Every guide to the types of startup funding walks you through pre-seed, seed, Series A, Series B as though it were a staircase everybody climbs. For roughly 999 founders in every 1,000, it is not.

So this guide does the thing the others skip. It lists the types — all of them, not just the venture ladder — and puts a price on each one. Not the cheque size. The cost.

Because the question is never “what types of startup funding exist.” It is “what does each one take from me, and can I afford it.”

The only distinction that actually matters

Forget the stage names for a moment. Every funding instrument in existence sits on one side of a single line.

Dilutive funding gives someone equity. Your ownership percentage drops permanently. Angels, accelerators, SAFEs, priced rounds, venture capital.

Non-dilutive funding does not. Grants, loans, venture debt, revenue-based financing, customer revenue. Your cap table is untouched. You may owe money instead.

Everything else — the letters, the round names, the instrument acronyms — is detail hanging off that one distinction.

The trap is assuming dilutive is worse. It is not. Pre-revenue companies often need equity capital precisely because it comes with credibility, network and follow-on commitment that a bank loan cannot provide. The mistake is taking dilutive money when non-dilutive money would have done the same job.

Non-dilutive types of startup funding

Bootstrapping

Funding growth from personal savings and customer revenue. No investors, no cap table, no board.

Cost: speed. You grow at the rate your revenue allows.

Worth knowing: Zoho turned down a $10 million venture offer in 2000 at a $200 million valuation. Founder Sridhar Vembu believed exit pressure would damage long-term thinking. Zoho today serves over 700,000 businesses, generates more than $1 billion in annual revenue, and remains founder-controlled after 30 years. Mailchimp raised zero venture capital across two decades.

Bootstrapping is not the consolation prize. It is a strategy with a track record.

Grants

Government schemes, innovation challenges, competitions, research funding. In India that means Startup India schemes; elsewhere the equivalents vary by country. Money you neither repay nor give equity for.

Cost: time and paperwork. Applications run for months, disbursement is milestone-based, and the reporting burden continues after the money lands.

The best capital that exists, and the hardest to get. Worth applying for at pre-product stage when you have more time than traction.

Venture debt

Loans made to venture-backed companies, usually alongside or shortly after an equity round.

Typical terms: sized at 25–50% of your most recent equity round, 8–12% interest, plus 0.1–0.5% warrant coverage. Often structured with an interest-only period followed by amortisation.

Cost: repayment obligation, and a small slice of equity through the warrants. Far cheaper than an equity round for the same amount.

Best used: to extend runway between priced rounds so you hit more milestones before your next valuation negotiation.

Revenue-based financing

Capital advanced against predictable recurring revenue, repaid as a percentage of monthly income. Payments flex with your business.

Cost: a share of revenue until the cap is repaid. No equity, no board seat.

The arithmetic is worth seeing. A founder who raises a $500,000 seed round at 20% dilution and separately takes $300,000 in revenue-based financing arrives at Series A having deployed $800,000 while giving up only 20%. Raising the full $800,000 in equity would have cost materially more of the company.

Best fit: SaaS, subscription and D2C businesses with predictable monthly revenue.

Rewards platforms

Kickstarter, Indiegogo and similar. Backers pre-order a product before it exists.

Cost: delivery risk and platform fees. You now owe thousands of people a physical product on a timeline.

Best fit: consumer hardware and physical products with a demonstrable prototype. A poor fit for software or services.

Customer capital

The unglamorous one that appears last in every guide, including the ones ranking above this page.

Customers paying you. No dilution, no repayment, no counterparty, no deadline, no cap.

Cost: it requires having something to sell.

Dilutive types of startup funding

Friends and family

Small amounts from people who know you, usually at the idea stage, often on informal terms.

Cost: the relationship, if it goes badly. Document it properly even when it feels awkward. Especially then.

Angel investment

High-net-worth individuals writing personal cheques at pre-seed and seed, either directly or through syndicates and networks.

Cost: typically 10–20% at pre-seed. Angels move faster than funds and ask for less structure, but the good ones bring introductions worth more than the money.

Accelerators

Y Combinator, Techstars, Antler and hundreds of regional programmes. Capital plus mentorship, curriculum and demo day, usually for 2–8% equity.

Cost: a fixed slice at the point when your equity is cheapest, which is also when it is most valuable to you later.

Worth it when you need the network more than the money. Expensive when you only need the money.

Convertible instruments: SAFEs and notes

This is where most founders lose ownership without noticing, so it gets more space than the others.

Both instruments solve the same problem: you need cash now, but nobody wants to agree a valuation yet. Both delay the pricing conversation to a future round.

SAFEs

Simple Agreement for Future Equity. No interest, no maturity date, converts at a valuation cap or discount when you raise a priced round.

SAFEs are now the default. Carta reported them at a record 90% of all pre-seed rounds in Q1 2025, and still dominant through Q1 2026, with convertible notes falling to record-low shares of both rounds and dollars.

The post-money version is the standard, and the mechanics matter. With a post-money SAFE, the investor’s ownership is fixed by a simple formula: the SAFE amount divided by the post-money cap. A $500,000 SAFE at a $10 million cap is exactly 5% of your company. Predictable, and that is the point.

Here is the part that costs founders their companies. Under a post-money SAFE, every new SAFE you issue dilutes only the founders — not the SAFE holders who came before. Each investor’s percentage is locked as though no other SAFE exists.

Take three investors each putting in $1 million against the same $10 million cap. Under the older pre-money structure, total founder dilution comes to roughly 25%, shared across the pool. Under post-money SAFEs, each investor independently locks 10% — and the founders absorb all of it.

Stack $1.5 million of SAFEs at low caps and you can quietly sell a quarter of the company before Series A. Nothing feels wrong while it happens. There is no round to close, no term sheet to sign, no moment where the total is put in front of you. The reckoning arrives during Series A diligence, when everything goes into one spreadsheet.

Convertible notes

A loan that converts to equity. Carries interest, typically 4–8% as market practice, and a maturity date, typically 24 months.

Two costs founders underestimate.

The interest converts too. A $300,000 note at 5% over 24 months becomes $330,000 at conversion — around 10% more shares than the principal alone would have bought.

And the maturity date is real. If the note matures and you have not raised a priced round, you owe the money back. Most startups cannot repay a $500,000 note on demand, which hands the investor leverage at the worst possible moment. In practice extension is the common outcome — note investors are not in the lending business — but you are negotiating from weakness.

Which to use: for most pre-seed and seed rounds, a post-money SAFE is faster, cheaper and better understood. Notes suit bridge financing, investors who want creditor protection, and situations converting within a defined window.

Priced equity rounds

Where a valuation is agreed, shares are issued, and the cap table changes on the day.

The letters are not just bigger cheques. They map to what you have de-risked. Seed funds the hypothesis. Series A funds proof of product-market fit. Series B funds a repeatable go-to-market motion. Series C funds scaling something that already works.

The 2026 bar is higher than the guides written in 2021 suggest. Most Series A investors now want $1–2 million ARR growing 150%+ year on year. The conversion rate from seed to Series A has fallen from around 50% to roughly 38%. Median round sizes sit 30–50% below the 2021 peak.

The dilution maths nobody puts in the article

Here is what a clean, successful, textbook path through the funding types costs you.

Carta’s 2026 data puts the median founding team at about 56% after a seed round. Total dilution through Series A typically reaches 40–50%, with founders who raise all three rounds cleanly retaining 45–55%.

That is the good outcome. That is what it looks like when nothing goes wrong.

Three things that make it worse

The option pool. Investors almost always require a 10–15% employee option pool, and over 95% of term sheets specify it comes out of the pre-money valuation — meaning existing shareholders, mostly you, absorb it.

Convertible overhang. SAFEs and notes do not dilute on the day you sign. They dilute at conversion, often at a discount, adding 5–15% on top of the round itself. Founders routinely forget them until diligence.

Raising too often. Rounds six to eight months apart mean you have not grown enough between them to justify the new price. Flat rounds dilute without the value creation that makes dilution worthwhile.

Carta data indicates 28% of seed and Series A rounds involve selling 20–24% of the company, and nearly 10% sell over 30% — well past the point where the next round becomes difficult to price.

The type most guides leave out

There is a funding type that does not appear on the venture ladder and rarely makes these lists: capital from the people who would become your customers anyway.

Not a pre-order, and not a donation. A structure where backing a founder early earns something permanent.

That is the model behind JustStartUP. A backer pays to support a founder, earns a permanent Star Badge, and unlocks lifetime perks from that brand — discounts and early access — for as long as the brand exists. They still pay for what they buy; the perks are membership benefits, not free products. The founder keeps 100% of their equity. No shares, no board seat, no dilution.

The closest familiar structure is a Costco membership: you pay to be a member, and the membership pays you back in access and pricing for as long as you hold it. Or consider backing Apple in 1976 — first access to every product, and a permanent discount, for life.

Cost: you have to deliver on the perks, permanently. That is a real obligation, and it is the right one to have.

Best fit: consumer products, D2C brands, and founders with an audience who would rather keep their company than accelerate on someone else’s schedule. A poor fit for deep tech with a five-year path to first revenue.

Browse startups raising this way.

How to choose between the types

Four questions, in order.

Do you have revenue?

If yes, non-dilutive options open up that were closed before — revenue-based financing, venture debt, credit facilities. Use them before selling equity.

Do you need the money, or the network?

If the answer is the network, an accelerator or a well-connected angel is worth the equity. If it is purely the money, equity is the most expensive way to get it.

How fast does this market move?

Winner-take-most markets justify dilution to move faster. Markets where the second-best product still builds a good business usually do not.

How much do you want to own at the end?

The uncomfortable question, and the one that should be asked first. A founder who wants to run the company for twenty years and a founder who wants a five-year exit should choose completely different instruments, and most advice pretends they are the same person.

Frequently asked questions

What are the main types of startup funding?
Bootstrapping, grants, friends and family, angel investment, accelerators, convertible instruments such as SAFEs and notes, priced equity rounds, venture debt, revenue-based financing, rewards platforms, and customer revenue. They divide into two groups: those that take equity and those that do not.

What is the difference between dilutive and non-dilutive funding?
Dilutive funding exchanges capital for equity and permanently reduces your ownership. Non-dilutive funding — grants, loans, venture debt, revenue-based financing, customer revenue — leaves your cap table intact but may create a repayment obligation.

How much equity do founders give up per round?
Roughly 10–20% at pre-seed, 15–25% at seed, and 20–25% at Series A including the option pool refresh. Later rounds narrow to 5–12%. Total dilution through Series A typically reaches 40–50%.

What is a SAFE and how does it work?
A Simple Agreement for Future Equity. An investor gives you money now and receives shares later, when a priced round converts the SAFE at a valuation cap or discount. No interest, no maturity date. With a post-money SAFE, ownership equals the SAFE amount divided by the post-money cap.

Is a SAFE better than a convertible note?
For most pre-seed and seed rounds, yes — faster, cheaper, no interest and no maturity deadline. Notes suit bridge financing and investors who want creditor protection. Neither is automatically better.

What is the biggest hidden cost of SAFEs?
Stacking. Under post-money SAFEs, each new one dilutes only the founders, not earlier SAFE holders. Signing several over a few months can quietly cost a quarter of the company before Series A, with no single moment where the total is visible.

How much does venture debt cost?
Typically 8–12% interest plus 0.1–0.5% warrant coverage, sized at 25–50% of your most recent equity round. Considerably cheaper than raising the same amount in equity.

Can I raise startup funding without giving up equity?
Yes. Grants, venture debt, revenue-based financing, customer revenue and backer-based models are all non-dilutive. Most require either traction or patience, which is why founders reach for equity first.

What do I need to raise a Series A in 2026?
Most Series A investors want $1–2 million ARR growing 150%+ year on year, net revenue retention above 110%, and a credible path to $10 million ARR within 18–24 months. The seed-to-Series-A conversion rate has fallen from roughly 50% to about 38%.

Do most startups raise venture capital?
No. Fewer than 0.05% of US startups ever raise a VC round. The overwhelming majority are funded by revenue, personal savings, loans, or small amounts from people who know the founder.

The part to take with you

The types of startup funding are not a ladder. They are a menu, and the prices are printed in a currency most founders do not read carefully — percentage of company, permanently.

You can raise $800,000 and give up 20%, or raise the same $800,000 and give up 35%, depending purely on which instruments you use and in what order. That difference compounds through every subsequent round.

Fewer than one in two thousand startups takes the venture route. It is worth being certain you are that one before you price your company as though you were.

Want to fund without dilution? See how backing works on JustStartUP or browse startups raising now. More guides in Articles.

Sources: Carta · CRV — equity dilution · Dealroom — funding stages · Y Combinator · Investopedia — series funding

Round sizes, dilution norms and instrument terms change with the market. Figures reflect 2026 medians from Carta, PitchBook and Dealroom. Verify against current data and take legal advice before signing any instrument. Last updated August 2026.